Neuroreceptor imaging in psychiatry: theory and applications. (Q36314030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Neuroreceptor imaging in psychiatry: theory and applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

Peter S Talbot

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Mark Slifstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

Marc Laruelle

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

International Review of Neurobiology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

385-440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291028 AND SRC:MED&resulttype=core&format=json

Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The role of serotonin in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

How does pindolol improve antidepressant action?

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The neurobiology of social phobia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Emerging principles of altered neural circuitry in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Changes in metabolism of cerebral glucose after stereotactic leukotomy for refractory obsessive-compulsive disorder: a case report

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Evaluation of serotonergic transporters using PET and [11C]( )McN-5652: assessment of methods

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Regulation of 5-HT receptors by corticosteroids: where do we stand?

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A functional anatomy of anticipatory anxiety

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D2 receptors in schizophrenia studied in vivo

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Spectral analysis of dynamic PET studies

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT imaging of serotonin2 receptors in depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D2 receptors in depression measured with single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Evidence for a widespread dopaminergic innervation of the human cerebral neocortex

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The quest for biological correlates of social phobia: an interim assessment

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The role of dopamine in mood disorders

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Neuroimaging studies of mood disorders

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

PET imaging of serotonin 1A receptor binding in depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A Molecular and Cellular Theory of Depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A PET-study of [ 11 C]FLB 457 binding to extrastriatal D 2 -dopamine receptors in healthy subjects and antipsychotic drug-treated patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Inhibition of monoamine oxidase B in the brains of smokers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain monoamine oxidase A inhibition in cigarette smokers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The effect of ethanol and haloperidol on dopamine receptor (D2) density

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Time course of central nervous dopamine-D 2 and 5-HT 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel ® ) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Quantification of neuroreceptors in living human brain. v. endogenous neurotransmitter inhibition of haloperidol binding in psychosis

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin transporters in ecstasy users

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced central serotonin transporters in alcoholism

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Effect of ethanol administration of striatal D1 and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Molecular alterations in the neostriatum of human cocaine addicts

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

(-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Role of the dopaminergic system in depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Regional brain activity during transient self-induced anxiety and anger in healthy adults

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Evidence for striatal dopamine release during a video game

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Equilibrium versus Compartmental Analysis for Assessment of the Vesicular Monoamine Transporter Using ( )-α-[11C]Dihydrotetrabenazine (DTBZ) and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal dopamine transporter density in major depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Effects of ethanol on central dopamine functions

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine transporter availability and depressive symptoms during alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Comparison of methods for analysis of clinical [11C]raclopride studies.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Mesocorticolimbic dopaminergic network: functional and regulatory roles

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A method for the solution of certain non-linear problems in least squares

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Distribution volume ratios without blood sampling from graphical analysis of PET data

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Functional connectivity in depressive, obsessive-compulsive, and schizophrenic disorders: an explorative correlational analysis of regional cerebral metabolism

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

The effects of long-term ethanol on brain receptors for dopamine, acetylcholine, serotonin and noradrenaline

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Limbic selectivity of clozapine

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

PET brain imaging with [11C]( )McN5652 shows increased serotonin transporter availability in major depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Low dopamine D(2) receptor binding potential in social phobia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain dopamine receptors in schizophrenia: PET problems

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Clinical and psychometric correlates of dopamine D2 binding in depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[11C]( )McN5652 as a radiotracer for imaging serotonin uptake sites with PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

D1 dopamine receptor binding in mood disorders measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron Emission Tomography of 5-HT Transporter Sites in the Baboon Brain with [11C]McN5652

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine reuptake site densities in patients with social phobia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Modified regression model for the Logan plot

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain imaging in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and DirectIn VitroDeterminations

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Effects of chronic cocaine abuse on postsynaptic dopamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Regional brain metabolic response to lorazepam in subjects at risk for alcoholism.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Relationship between subjective effects of cocaine and dopamine transporter occupancy

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreases in dopamine receptors but not in dopamine transporters in alcoholics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Cocaine uptake is decreased in the brain of detoxified cocaine abusers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased cerebral response to inhibitory neurotransmission in alcoholics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Cocaine abusers do not show loss of dopamine transporters with age

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain dopamine and obesity

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Enantioselectivity of cocaine recognition sites: binding of (1S)- and (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane (beta-CIT) to monoamine transporters.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Prefrontal function in schizophrenia: confounds and controversies

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decreased 5-HT1A receptor binding in amygdala of schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Brain serotonin2 receptors in major depression: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

High levels of dopamine activity in the basal ganglia of cigarette smokers

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(05)67011-0

7 January 2021